TI
TTNP

tru Independence’s Titan Pharmaceuticals TTNP Stock Holding History

tru Independence’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-175
Closed -$11.5K – 680
2020
Q4 		$11.5K Buy
+175
New +$13.8K 0.02% 246
2020
Q3 		– Sell
-26
Closed -$4 – 818
2020
Q2 		$4 Buy
+26
New +$4.48K ﹤0.01% 750

Other funds holding TTNP

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

tru Independence's TTNP Position: Q1 2021 in Review

tru Independence sold out of Titan Pharmaceuticals (TTNP) in Q1 2021, closing a stake of 175 shares — an estimated $11.5K sold.

tru Independence first reported a position in TTNP in Q2 2020 and held it in 2 quarters. The position peaked at $11.5K in Q4 2020. 20 funds tracked by Wall St. Rank hold TTNP as of Q1 2021.

  • tru Independence reported no remaining Titan Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • tru Independence sold 175 Titan Pharmaceuticals shares in Q1 2021, an estimated $11.5K.
  • tru Independence first reported a position in Titan Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • tru Independence's Titan Pharmaceuticals position peaked at $11.5K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2021.

Based on tru Independence's 13F filing for Q1 2021, filed 20 May 2021.